@article{ref1,
title="Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature",
journal="Clinical toxicology (Philadelphia, Pa.)",
year="2007",
author="Oliva, Antonio and De Giorgio, Fabio and Arena, Vincenzo and Fucci, Nadia and Pascali, Vincenzo Lorenzo and Navarra, Pierluigi",
volume="45",
number="6",
pages="709-713",
abstract="A fatality due to the intravenous self-injection of Ketorolac (Toradol) is reported. Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) with marked analgesic activity. There is limited information of fatalities attributed to ketorolac toxicity. Here we report the case of a 53-year-old woman with a medical history of depression that was found deceased at home with no evidence of trauma or injuries. Near the body, a syringe and three empty vials (30 mg) of Toradol were found. A fresh needle mark on the right arm was noticed. Toxicological analyses were performed using a gas chromatography-mass spectrometry (GC/MS) technique. The estimated ketorolac concentration in the blood was 8 mug/ml; urine and gastric content were negative for this compound. Based on the autopsy, histologic findings and toxicological results of anaphylactic shock associated with ketorolac self-administration was assumed to be the underlying pathophysiological mechanism of death and the manner, suicide.<p /> <p>Language: en</p>",
language="en",
issn="1556-3650",
doi="10.1080/15563650701397076",
url="http://dx.doi.org/10.1080/15563650701397076"
}